DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / A•••••• L••• S•••••••• I•••
A•••••• L••• S•••••••• I•••
A•••••• L••• S•••••••• I••• Changing the way Cell Sorting & Cell Isolation is performed. Contact Us for faster & higher viabile Cell Separation Technology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
1 rounds
- Apr 11, 2025Form D equity offering · $5.6M (form d sold) · 35 investorsFact SEC EDGAR Form D data sets (quarterly) · “A•••••• L••• S•••••••• I••• filed Form D: $5,633,565 sold of $7,150,000, Biotechnology”
Investors on record
2 edges
- A•••••••• V••••••• portfolio listing Fact arboretumvc.com
- W•••••• T••••••••• I••••••••• •••• portfolio listing Fact westerntech.com
People
2 officers, 3 directors
- B•••••• M••••••••• Executive Officer/Director sec.gov
- J•••• S• M•••••••• Executive Officer sec.gov
- J•••••• S• W••••••• Director Fact
- P••• D•••••• Director Fact
- D•• K•••• Director Fact
Timeline
1
- Apr 25, 2025A•••••• L••• S•••••••• I••• filed Form D: $5,633,565 sold of $7,150,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
21 observations
Every observation on this company
- Description: A•••••• L••• S•••••••• I••• Changing the way Cell Sorting & Cell Isolation is performed. Contact Us for faster & higher viabile Cell Separation T••••••••• Sep 16, 2026 Fact Portfolio company websites (about, investors, press pages)
- Entity type: Corporation Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $5.6M Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $7.2M Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-04-11 Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 35 Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity,option Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 674 S WAGNER RD., ANN ARBOR, MI, 48103 Apr 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: W•••••• T••••••••• I••••••••• •••• Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: A•••••••• V••••••• Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: W•••••• T••••••••• I••••••••• •••• Sep 15, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: A•••••••• V••••••• Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 16, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: Better Cell Separation T••••••••• | A•••••• L••• S••••••• Sep 16, 2026 Fact Portfolio company websites (about, investors, press pages)